June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Comparison of galectin expression signature in rejected and accepted murine corneal allografts
Author Affiliations & Notes
  • Satoshi Sugaya
    Ophthalmology, New England Eye center / Tufts university school of medicine, Boston, MA
  • Wei-Sheng Chen
    Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA
  • Zhiyi Cao
    Ophthalmology, New England Eye center / Tufts university school of medicine, Boston, MA
  • Kenneth Kenyon
    Ophthalmology, New England Eye center / Tufts university school of medicine, Boston, MA
  • Takefumi Yamaguchi
    Ophthalmology, Schepens Eye Research Institute / Massachusetts Eye and Ear, Boston, MA
  • Masahiro Omoto
    Ophthalmology, Schepens Eye Research Institute / Massachusetts Eye and Ear, Boston, MA
  • Pedram Hamrah
    Ophthalmology, Schepens Eye Research Institute / Massachusetts Eye and Ear, Boston, MA
  • Noorjahan A Panjwani
    Ophthalmology, New England Eye center / Tufts university school of medicine, Boston, MA
    Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA
  • Footnotes
    Commercial Relationships Satoshi Sugaya, None; Wei-Sheng Chen, None; Zhiyi Cao, None; Kenneth Kenyon, None; Takefumi Yamaguchi, None; Masahiro Omoto, None; Pedram Hamrah, None; Noorjahan Panjwani, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4029. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Satoshi Sugaya, Wei-Sheng Chen, Zhiyi Cao, Kenneth Kenyon, Takefumi Yamaguchi, Masahiro Omoto, Pedram Hamrah, Noorjahan A Panjwani; Comparison of galectin expression signature in rejected and accepted murine corneal allografts. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4029.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Although the members of the galectin family of carbohydrate-binding proteins are thought to play a role in immune response and the regulation of allograft survival, little is known about the galectin expression signature in failed corneal grafts. The goal of this study was to compare the galectin expression pattern in the rejected and accepted murine corneal allografts.

Methods: Using BALB/c mice as graft recipients and C57BL/6 mice as graft donors, a total of 57 transplants were performed. One week after transplantation, the grafts were scored for opacity by slit-lamp microscopy. Initially clear grafts which develop opacity score of 3+ or greater on postoperative week 4 were considered rejected. All grafted corneas were harvested on postoperative week 4, and their galectin expression was analyzed by Western blot and immunofluorescence staining.

Results: As determined by Western blot analyses, galectins-1, -3, -7, -8 and -9 were expressed in normal corneas. Although, in both accepted and rejected grafts, protein expression levels of galectins-1, -3, -7, -8 and -9 were upregulated compared to normal corneas, there were distinct differences in the expression level of galectins-8 and -9 between accepted and rejected grafts. Galectin-8 was downregulated, whereas galectin-9 was upregulated in accepted grafts compared to rejected grafts. Consistent with these findings, in immunofluorescence staining, galectin-8 expression in accepted grafts was lower than in the stroma of rejected grafts, whereas galectin-9 immunoreactivity was stronger in accepted grafts compared to rejected grafts.

Conclusions: Our findings that corneal allograft rejection is associated with increased galectin-8 expression and reduced galectin-9 expression, lead us to hypothesize that galectin-8 may reduce graft survival, whereas galectin-9 may promote graft survival. As a potential therapeutic intervention, inhibition of galectin-8 and/or treatment with exogenous galectin-9 may enhance corneal allograft survival rates.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×